What's New

  • 29 Nov 2018
    Antares Pharma Announces The Commercial Availability Of XYOSTED™ (Testosterone Enanthate ) Injection – A New Treatment For Adult Men Diagnosed With Testosterone Deficiency Read More

  • 27 Nov 2018
    Antares Pharma Partner TEVA Announces Commercial Availability of Generic EpiPen Read More

  • 26 Nov 2018
    Antares Pharma to Present at the 30th Annual Piper Jaffray Healthcare Conference Read More

ATRS

Quotes delayed at least 15 minutes